Ironwood Pharmaceuticals (NASDAQ:IRWD): Q4 Non-GAAP EPS of $0.30 beats by $0.07; GAAP EPS of $0.30 beats by $0.08.
Revenue of $126.3M (-3.4% Y/Y) beats by $14.24M.
https://seekingalpha.com/news/3541622-ironwood-pharmaceuticals-eps-beats-0_07-beats-on-revenue
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.